A new system may help solve the problem of shipping cells between laboratories and hospitals and clinics by developing an alternative to cryopreservation.
Engineering and manufacturing expertise could ease the shortage of viral vectors used for drug delivery in the booming gene therapy market.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
In the wake of recent developments in the field of cell therapy, bioprinter vendors are seeking to market to more sophisticated researchers.
New technologies for engineering cells, monitoring cellular attributes and accelerating manufacturing lead to better and safer cell therapy products.
Scientists are now developing alternative strategies for producing new types of CAR-T treatments.
Encellin is working to eliminate insulin injections for diabetic patients with an insulin-producing implant containing live cells.
New classes of molecules based on naturally occurring sugars promise to preserve cryogenically frozen cells and perhaps organs without any of the toxic side effects of current treatment.
The FDA recently announced an exciting new class of cancer drug made from a patient’s own cells, and it is clear that engineers will play a key role in fulfilling its promise.
Dr. Denis Wirtz discusses how cells turn rogue, escape incarceration, and become a cancer upon their surroundings.
In a podcast recorded at the 2017 SB3C summer conference, Prof. Yaling Liu, Lehigh University, discusses his work using microfluidic devices to capture circulating tumor cells.
A common virus may hold the key for the nearly 50 percent of patients who do not respond to immunotherapy cancer treatment.
A multicenter, NSF-funded research team is building machines with new functionalities out of living cells.
Studying the binding and unbinding of molecules could lead to better insights into the study of antibodies.
A liquid biopsy chip measures metastatic breast cancer cells in the bloodstream with great precision.